Meta-analysis of the Gut Microbiome in Inflammatory Bowel Disease

We aim to conduct a meta-analysis on the role of the gut microbiome in inflammatory bowel disease (IBD). By incorporating shotgun metagenomic sequencing data from various cohorts, we hope to develop a more comprehensive and generalizable understanding of microbial signatures associated with IBD phenotypes, disease progression, and treatment responses. Furthermore, this analysis has the potential to identify novel microbial biomarkers or therapeutic targets associated with IBD. The sequencing data from the requested study will be a critical component of our meta-analysis dataset.